Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Concurrent Methotrexate and Etretinate Therapy for Psoriasis

Concurrent Methotrexate and Etretinate Therapy for Psoriasis Abstract To the Editor.— I read with interest the report by Vanderveen et al in the September Archives (1982;118:660-662) concerning the use of methotrexate and etretinate as concurrent therapies in severe psoriasis. I would like to add an almost identical case to the record. The possibility of drug interactions makes it important to document safe and successful treatment regimens.I saw a 46-year-old man who had suffered from severe erythrodermic and exfoliative psoriasis for seven years. In the previous two years the patient had spent half of his life as a hospital inpatient for treatment of his disease. The basic therapy had been coal tar ointment applied topically and weekly intravenous (IV) methotrexate. During 1982 episodes of pustulation began on the limbs, associated with fever and leukocytosis. In September he was extremely ill with staphylococcal bacteremia and it was decided to add etretinate to his therapy. Having had no previous experience References 1. Adams JD, Hunter GA: Drug interaction in psoriasis . Australas J Dermatol 1976;17:39-40.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Concurrent Methotrexate and Etretinate Therapy for Psoriasis

Archives of Dermatology , Volume 119 (10) – Oct 1, 1983

Concurrent Methotrexate and Etretinate Therapy for Psoriasis

Abstract

Abstract To the Editor.— I read with interest the report by Vanderveen et al in the September Archives (1982;118:660-662) concerning the use of methotrexate and etretinate as concurrent therapies in severe psoriasis. I would like to add an almost identical case to the record. The possibility of drug interactions makes it important to document safe and successful treatment regimens.I saw a 46-year-old man who had suffered from severe erythrodermic and exfoliative psoriasis for seven...
Loading next page...
 
/lp/american-medical-association/concurrent-methotrexate-and-etretinate-therapy-for-psoriasis-0D4lyW3ziw
Publisher
American Medical Association
Copyright
Copyright © 1983 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1983.01650340003007
Publisher site
See Article on Publisher Site

Abstract

Abstract To the Editor.— I read with interest the report by Vanderveen et al in the September Archives (1982;118:660-662) concerning the use of methotrexate and etretinate as concurrent therapies in severe psoriasis. I would like to add an almost identical case to the record. The possibility of drug interactions makes it important to document safe and successful treatment regimens.I saw a 46-year-old man who had suffered from severe erythrodermic and exfoliative psoriasis for seven years. In the previous two years the patient had spent half of his life as a hospital inpatient for treatment of his disease. The basic therapy had been coal tar ointment applied topically and weekly intravenous (IV) methotrexate. During 1982 episodes of pustulation began on the limbs, associated with fever and leukocytosis. In September he was extremely ill with staphylococcal bacteremia and it was decided to add etretinate to his therapy. Having had no previous experience References 1. Adams JD, Hunter GA: Drug interaction in psoriasis . Australas J Dermatol 1976;17:39-40.Crossref

Journal

Archives of DermatologyAmerican Medical Association

Published: Oct 1, 1983

References